PACS Group, Inc. (NYSE:PACS – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the eight ratings firms that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $61.33.
PACS has been the topic of a number of recent research reports. UBS Group upped their price target on shares of PACS Group from $60.00 to $67.00 and gave the company a “buy” rating in a research note on Thursday, November 5th. Truist Financial reiterated a “buy” rating and issued a $65.00 price objective (up from $62.00) on shares of PACS Group in a research note on Thursday, November 5th. Zacks Research cut shares of PACS Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, September 9th. Stephens boosted their target price on shares of PACS Group from $60.00 to $64.00 and gave the company an “overweight” rating in a report on Thursday, November 5th. Finally, JPMorgan Chase & Co. increased their target price on PACS Group from $47.00 to $58.00 and gave the stock an “overweight” rating in a research report on Friday, September 4th.
Check Out Our Latest Analysis on PACS
PACS Group Price Performance
PACS Group (NYSE:PACS – Get Free Report) last issued its earnings results on Tuesday, November 3rd. The company reported $0.63 earnings per share for the quarter, topping analysts’ consensus estimates of $0.58 by $0.05. The firm had revenue of $1.50 billion during the quarter, compared to analyst estimates of $1.46 billion. PACS Group had a net margin of 4.87% and a return on equity of 31.98%. Research analysts predict that PACS Group will post 2.05 earnings per share for the current year.
Insider Buying and Selling at PACS Group
In related news, CEO Jason Murray sold 167,434 shares of the stock in a transaction dated Wednesday, November 4th. The stock was sold at an average price of $50.24, for a total transaction of $8,411,884.16. Following the sale, the chief executive officer owned 53,954,101 shares of the company’s stock, valued at approximately $2,710,654,034.24. This represents a 0.31% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Mark Hancock sold 186,696 shares of the firm’s stock in a transaction dated Wednesday, November 4th. The stock was sold at an average price of $50.45, for a total value of $9,418,813.20. Following the completion of the transaction, the director owned 53,318,884 shares of the company’s stock, valued at approximately $2,689,937,697.80. This represents a 0.35% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 1,741,666 shares of company stock valued at $79,836,513. 70.10% of the stock is owned by company insiders.
Institutional Inflows and Outflows
A number of hedge funds have recently added to or reduced their stakes in the stock. Cantor Fitzgerald Investment Advisors L.P. bought a new position in shares of PACS Group in the third quarter valued at approximately $1,920,000. Squarepoint Ops LLC grew its stake in PACS Group by 94.7% during the second quarter. Squarepoint Ops LLC now owns 59,523 shares of the company’s stock valued at $2,538,000 after acquiring an additional 28,945 shares in the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in PACS Group during the second quarter valued at approximately $1,893,000. Engineers Gate Manager LP purchased a new position in PACS Group during the second quarter valued at approximately $1,132,000. Finally, Smith Group Asset Management LLC bought a new stake in PACS Group during the 1st quarter worth approximately $771,000.
PACS Group Company Profile
PACS Group, Inc. is a post-acute healthcare provider that operates skilled nursing and rehabilitation facilities. Its services include nursing care, physical and occupational therapy, and support for patients recovering from illness or injury, as well as care for people with ongoing or long-term needs. Founded in 2013, the company has expanded its network of facilities across the United States. Its operations are organized through affiliated entities, with care and services tailored to the needs of residents and patients in the communities it serves.
See Also
- Five stocks we like better than PACS Group
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.
